LAURA CURE: Open Payments
NPI 1225746878 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,399 in 113 payments from 26 companies in 2025. Trend: 2023 $574 · 2024 $2,208 · 2025 $2,399
Food & beverage: $2,399
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $460 |
| Novo Nordisk Inc | 15 | $400 |
| GlaxoSmithKline, LLC. | 13 | $217 |
| AstraZeneca Pharmaceuticals LP | 8 | $186 |
| Exact Sciences Corporation | 7 | $166 |
| Axsome Therapeutics, Inc. | 5 | $112 |
| Amgen Inc. | 6 | $96 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $72 |
| PFIZER INC. | 3 | $67 |
| Dexcom, Inc. | 3 | $66 |
Products named: Wegovy, The Cologuard Plus Collection Kit, VRAYLAR, QULIPTA, UBRELVY, Auvelity, SHINGRIX, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
